A Randomized Phase III Study of Decitabine (DAC) With or Without Hydroxyurea (HY) Versus HY in Patients With Advanced Proliferative Chronic Myelomonocytic Leukemia (CMML)
Phase of Trial: Phase III
Latest Information Update: 14 Jul 2017
At a glance
- Drugs Decitabine (Primary) ; Hydroxycarbamide
- Indications Chronic myelomonocytic leukaemia
- Focus Therapeutic Use
- 11 Jul 2017 Planned primary completion date changed from 1 Oct 2016 to 1 Dec 2017.
- 10 Jun 2017 Biomarkers information updated
- 13 Apr 2016 Planned End Date changed from 1 Aug 2018 to 1 Oct 2018.